D-Wave And Quantum Computing: Taking Profits On The Pair, Waiting For The Next Gap

D-Wave Quantum (QBTS) remains valued at a premium to Quantum Computing (QUBT), but improving technical execution, recurring cloud revenue, and a growing production-application mix weaken the short thesis. QUBT's recent revenue growth is characterized as acquisition-driven rather than evidence of underlying quantum-computing demand. The outlook favors QBTS's strategic progress and technical roadmap, while maintaining valuation-related caution.

Analysis

The investable distinction is revenue quality rather than headline growth. QBTS can earn relative multiple support if recurring cloud usage converts into contracted enterprise spend, because that improves forecastability and reduces reliance on periodic hardware/project bookings; QUBT remains vulnerable if investors separate acquired operating revenue from quantum-derived demand. The near-term setup therefore favors a relative-value expression rather than a directional quantum-sector bet, where both names remain highly flow-driven and sensitive to retail risk appetite.

Over the next 1-3 months, earnings disclosures around bookings, recurring-revenue mix, gross margin and cash burn are the key catalysts. A rising recurring mix at QBTS would support continued narrative re-rating, while any evidence that QUBT's acquired revenue has low organic growth, weak margins, or limited cross-sell into quantum products could compress its premium. The critical missing diligence items are customer concentration, contract duration, backlog conversion, and the dilution required to fund each company's roadmap.

The contrarian risk is that neither company has yet demonstrated an economics profile sufficient to justify valuations driven by technological optionality. IBM, GOOG and other well-capitalized platforms can commoditize access to quantum compute before smaller pure plays establish durable pricing power; conversely, a credible technical benchmark or major commercial contract could trigger sharp short-covering regardless of current fundamentals. Treat technical roadmap milestones as sentiment catalysts, not revenue catalysts, until independently validated by paid production deployments.

Key Decisions for Investors

• Initiate a 3-month market-neutral pair: long QBTS / short QUBT, sized modestly given high volatility and potential borrow costs. Add only after the next reporting cycle confirms QBTS recurring-revenue growth and QUBT discloses limited organic growth; target a 15-25% relative return, with a 10% adverse relative-performance stop.
• Do not establish an outright QBTS short solely on valuation. Reassess a short only if cash runway falls below 12 months, recurring revenue stalls for two consecutive quarters, or management reduces commercial deployment guidance; these would convert the valuation concern into a financing-risk thesis.
• Use QUBT earnings as an event watch: a widening gap between reported revenue growth and organic growth/gross-margin progression is a short catalyst. If the company reports credible organic bookings, expanding margins, and named production customers, cover the relative short rather than averaging up.
• For broad quantum exposure, prefer limited-risk structures over common equity until cash-burn and customer-retention data improve. A small QBTS call spread dated 6-9 months can express upside from commercial validation while capping downside; avoid if implied volatility makes the maximum gain less than 2x premium paid.